Serodeconversion of HIV antibody-positive AIDS patients following treatment with V-1 Immunitor.
J Biomed Biotechnol 2008;
2009:934579. [PMID:
18989372 PMCID:
PMC2577775 DOI:
10.1155/2009/934579]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2008] [Revised: 08/07/2008] [Accepted: 09/07/2008] [Indexed: 11/17/2022] Open
Abstract
It is extremely rare when HIV seropositive adult patients experience spontaneous loss
of antibodies, that is, seroreversion. The disappearance of HIV antibodies was occasionally
attributed to iatrogenic intervention—serodeconversion. Such interventions include:
HAART; oral interferon; Chinese herbal remedies; and therapeutic AIDS vaccines
derived from pooled blood. Oral therapeutic, alloimmune AIDS vaccine, V-1 Immunitor
(V1), was administered to 60000 HIV-positive Thai patients. The administration of V1
resulted in serodeconversion among 23 individuals. The patient group consisted of 9
females (39%) and 14 males (61%) including two 2-year-old boys. The age range was
2–58 years with mean/median 29/29.3 years. Patients were tested seropositive for HIV
at least once before being enrolled on V1. The duration of treatment until discovery of
seronegative status ranged between 2 weeks and 15 months with average/median 7.2/8
months. Time to seronegativity was correlated with baseline disease stage (R = 0.62; P = .002). The seronegative status was positively associated with V1-induced
undetectable or low viral load (R = 0.65; P = .0008). The odds ratio analysis comparing
the outcome of our study with published surveys of diagnostic accuracy of laboratory
tests suggested that the probability of HIV antibody testing error was remote
(P < .000001). The possible causes responsible for this unusual phenomenon are
discussed.
Collapse